Sanford Cancer Center

The trials here

What the 17 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer8 trials
• Colorectal cancer7 trials
• Lung cancer7 trials
• Bladder cancer3 trials
• Cervical cancer3 trials
• Gastric and oesophageal cancer3 trials
• Melanoma3 trials
• Kidney cancer2 trials
• Ovarian cancer2 trials
• Pancreatic cancer2 trials
• Endometrial cancer1 trial
• Liver and biliary tract cancer1 trial
• and 5 more

Phase

• Phase 25 trials
• Phase 14 trials
• Phase 34 trials
• Phase 1/22 trials
• Phase 2/31 trial

Status

• Recruiting7 trials
• Active, not recruiting5 trials
• Completed3 trials
• Terminated2 trials

Lead sponsor

• Bristol-Myers Squibb2 trials
• Washington University School of Medicine2 trials
• Astellas Pharma Global Development, Inc.1 trial
• BioNTech SE1 trial
• Eli Lilly and Company1 trial
• and 10 more

Running trials

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· Phase 2/3· Bristol-Myers Squibb· Source

  Contact: Jonathan Bleeker, Site 0312

• Recruiting

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· Phase 3· Eli Lilly and Company· Source

  Contact: Allison Watson (principal investigator)

• Recruiting

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  NCT06340568· Phase 3· BioNTech SE· Source

• Recruiting

  The Minimalist Trial-2

  NCT06702033· Phase 2· Washington University School of Medicine· Source

  Contact: Steven Powell, M.D.

• Recruiting

  A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

  NCT06646276· Phase 3· Bristol-Myers Squibb· Source

  Contact: Allison Watson, Site 0231

• Active, not recruiting

  A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors

  NCT05848739· Phase 1· Sapience Therapeutics· Source

• Active, not recruiting

  CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

  NCT05210283· Exact Sciences Corporation· Source

• Recruiting

  Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  NCT04614103· Phase 2· Iovance Biotherapeutics, Inc.· Source

  Contact: Iovance Biotherapeutics Study Team lungcelltherapy.com

• Recruiting

  A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  NCT04389632· Phase 1· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  NCT04291105· Phase 2· Vyriad, Inc.· Source

• Active, not recruiting

  NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

  NCT03589339· Phase 1· Nanobiotix· Source

• Active, not recruiting

  A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

  NCT03504397· Phase 3· Astellas Pharma Global Development, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer3 recruiting
• Head and neck cancer2 recruiting
• Bladder cancer1 recruiting
• Cervical cancer1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

  NCT05864144· Phase 1/2· Sensei Biotherapeutics, Inc.· Source

• Completed

  Phase 2 Study of DKN-01 in Colorectal Cancer

  NCT05480306· Phase 2· Leap Therapeutics, Inc.· Source

• Terminated

  Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

  NCT04795713· Phase 1· Molecular Templates, Inc.· Source

• Terminated

  A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

  NCT04844073· Phase 1/2· Takeda· Source

• Completed

  Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

  NCT02573493· Phase 2· Washington University School of Medicine· Source